Visualizing the Choriocapillaris Under Drusen: Comparing 1050-nm Swept-Source Versus 840-nm Spectral-Domain Optical Coherence Tomography Angiography by Lane, Mark et al.
Special Issue
Visualizing the Choriocapillaris Under Drusen: Comparing
1050-nm Swept-Source Versus 840-nm Spectral-Domain
Optical Coherence Tomography Angiography
Mark Lane,1,2 Eric M. Moult,3 Eduardo A. Novais,1,4 Ricardo N. Louzada,1,5 Emily D. Cole,1
ByungKun Lee,3 Lennart Husvogt,3,6 Pearse A. Keane,7 Alastair K. Denniston,2,8 Andre´ J. Witkin,1
Caroline R. Baumal,1 James G. Fujimoto,3 Jay S. Duker,1 and Nadia K. Waheed1
1New England Eye Center, Tufts Medical Center, Boston, Massachusetts, United States
2Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
3Department of Electrical Engineering and Computer Science, and Research Laboratory of Electronics, Massachusetts Institute of
Technology, Cambridge, Massachusetts, United States
4Federal University of Sa˜o Paulo, School of Medicine, Sa˜o Paulo, Brazil
5Federal University of Goia´s, Goiaˆnia, Brazil
6Pattern Recognition Lab, Friedrich-Alexander University Erlangen-Nu¨rnberg (FAU), Erlangen-Nu¨rnberg, Germany
7NIHR Biomedical Research Center for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of
Ophthalmology, London, United Kingdom
8Birmingham & Midland Eye Center, Sandwell and West Birmingham NHS Trust, Birmingham, United Kingdom
Correspondence: Nadia K. Waheed,
New England Eye Center, Tufts
Medical Center, 260 Tremont Street,
Biewend 10, Boston, MA 02116,
USA;
nadiakwaheed@gmail.com.
ML and EMM are joint first authors.
Submitted: December 14, 2015
Accepted: June 16, 2016
Citation: Lane M, Moult EM, Novais
EA, et al. Visualizing the choriocapil-
laris under drusen: comparing 1050-
nm swept-source versus 840-nm
spectral-domain optical coherence to-
mography angiography. Invest Oph-
thalmol Vis Sci. 2016;57:OCT585–
OCT590. DOI:10.1167/iovs.15-18915
PURPOSE. To investigate the appearance of choriocapillaris (CC) flow under drusen by
comparing long-wavelength (1050 nm) swept-source optical coherence tomography (SS-OCT)
angiography with shorter-wavelength (840 nm) spectral-domain (SD) OCT angiography.
METHODS. Patients with drusen imaged on both devices on the same day were selected and
graded. Ambiguous OCT angiography (OCTA) signal loss was defined as low OCTA signal on
the en face OCTA CC image that also had low OCT signal in the corresponding area on the en
face OCT CC image and OCT B-scans. Unambiguous OCTA signal loss was defined as low
OCTA signal on the en face OCTA CC image that did not have low OCT signal in the
corresponding area on the en face OCT CC image and OCT B-scans. False-positive flow
impairment on SS-OCTA was defined as ambiguous OCTA signal loss on SS-OCTA but no OCTA
signal loss on SD-OCTA. False-positive flow impairment on SD-OCTA was defined as
ambiguous OCTA signal loss on SD-OCTA but no OCTA signal loss on SS-OCTA.
RESULTS. Nine eyes from seven patients were enrolled, 23 drusen were analyzed. On 840-nm
SD-OCTA, 17 drusen (73.9%) exhibited OCTA signal loss. Fourteen (82.4%) were classified as
ambiguous, and three (17.6%) were classified as unambiguous; 10 (58.8%) were classified as
having false-positive flow impairment. On 1050-nm SS-OCTA, seven drusen (30.4%) exhibited
OCTA signal loss and were classified as unambiguous; none were classified as having false-
positive flow impairment.
CONCLUSIONS. Results showed that 1050-nm SS-OCTA appears less prone to producing areas of
false-positive flow impairment under drusen.
Keywords: optical coherence tomography, angiography, age-related macular degeneration,
choriocapillaris
Age-related macular degeneration (AMD) is the leading causeof irreversible blindness in adults older than 50 years in
developed countries.1–3 Globally, AMD accounts for 8.7% of all
blindness and is predicted to affect 196 million people by
2020.4 Early and intermediate AMD is characterized by soft
drusen, which can be observed by fundoscopic examination as
yellow deposits that lie between the retinal pigment epithelium
(RPE) and the anterior collagenous layer of Bruch’s mem-
brane.5,6
The choroid is an extensive vascular network, consisting
of an outer macrovascular layer and an inner capillary layer
called the choriocapillaris (CC), which lies immediately
below Bruch’s membrane. The choroidal circulation provides
70% of the total blood flow to the eye, providing nutrients
and removing waste products from the outer retinal
structures.7,8 Histopathologic studies have implicated CC
loss as a risk factor for the development of AMD.8–13 Many
articles have indicated that the site of drusen formation is
not random, but rather is influenced by CC dysfunction. In
particular, it has been suggested that drusen are more likely
to form at sites of insufficient choroidal perfusion, secondary
to vascular endothelial cell loss.14–17 It is for this reason that
drusen formation is often used as a surrogate marker for CC
dysfunction.
Clinically, fluorescein angiography (FA) and indocyanine
green angiography (ICGA) are considered the gold standards for
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imaging the retinal and choroidal vasculatures.18–20 Prolonged
choroidal filling is a common feature of early AMD on both FA
and ICGA, and indicates a vascular insufficiency that has a
predilection for sites underlying drusen.21 Unfortunately, the
microvascular architecture is often obscured by subsequent
hyperfluorescence in the late phase of dye transit, which can
limit precise assessment of CC loss and dysfunction in AMD. In
addition, these modalities are invasive, involving the use of
intravenous contrast that can result in systemic side effects,
such as nausea, vomiting, and, rarely, anaphylaxis.22–24
Optical coherence tomography angiography (OCTA) is a
noninvasive modality that generates depth-resolved images of the
ocular vasculature by acquiring repeated B-scans from the same
retinal location.25–31 The OCTA signal describes the pixel-by-
pixel changes that occur in the repeated B-scans as a result of
erythrocyte movement. Specifically, if the imaged tissue is
stationary, the repeated B-scans will be identical, and no OCTA
signal will be generated. Conversely, if the tissue contains
flowing erythrocytes, the repeated B-scans will exhibit an
intensity time variation that can be extracted and displayed.
Spectral-domain OCTA (SD-OCTA) provides excellent visual-
ization of the retinal vasculature and also allows for visualization
of the choroidal vasculature. However, the shorter, ~840-nm,
center wavelength typically used in commercial SD-OCT
systems is strongly attenuated by the RPE; this attenuation can
become more severe in the presence of RPE clumping and
drusen. Furthermore, the spectrometer-based detection used in
SD-OCT is susceptible to so-called sensitivity roll-off, the
phenomenon whereby the sensitivity to retinal features farther
from the system’s zero-delay is lower than for retinal features
that are closer to the system’s zero-delay. When using the
vitreoretinal imaging protocol with SD-OCT, sensitivity roll-off
reduces the signal levels detected from the choroid region; CC
imaging protocols with the SD-OCT system, whereby the CC is
located near the top of the B-scan, closer to the system’s zero-
delay, do not suffer from sensitivity roll-off. Both RPE attenuation
and sensitivity roll-off can result in low signal areas in choroidal
regions, especially in areas below drusen.
Compared to shorter-wavelength SD-OCT, our prototype
swept-source OCT (SS-OCT) system offers two distinct
advantages: first, the longer, ~1050-nm, center wavelength
used in our SS-OCT systems is less attenuated by the RPE32,33;
second, SS-OCT does not use spectrometer-based detection
and is less susceptible to sensitivity roll-off. In particular,
sensitivity roll-off in SS-OCT systems is determined by the
instantaneous linewidth of the swept light source, along with
the A/D acquisition. Together these two characteristics make
SS-OCT less susceptible to low signal in regions below the RPE.
In the context of OCTA, areas of low OCT signal, which are
heavily influenced by noise, produce unreliable, typically large,
OCTA signals. Because of this, OCTA images are thresholded
on the basis of the OCT signal level: OCTA pixels whose
corresponding OCT signal level is below a predefined
threshold are set to zero. This thresholding process prevents
low OCT signal areas, such as the vitreous, from exhibiting a
high OCTA signal, which is typically interpreted as corre-
sponding to blood flow. However, thresholding OCTA images
causes areas of low OCT signal to appear black on OCTA,
irrespective of their blood flow status. Thus, the thresholding
process introduces an ambiguity: it is no longer possible, from
looking at the OCT and OCTA images alone, to ascertain if an
area of low OCTA signal corresponds to low flow, low OCT
signal, or both. Consequentially, thresholded OCTA images
must be interpreted with care, and OCTA should always be
viewed with the corresponding OCT so that OCT signal levels
can be assessed.
The purpose of this study was to test the hypothesis that
longer-wavelength, 1050-nm, SS-OCTA is less prone to produc-
ing areas of false-positive flow impairment than shorter-
wavelength, 840-nm, SD-OCTA when imaging the CC under-
neath drusen.
METHODS
This was a retrospective case series conducted at the New
England Eye Center (NEEC) of Tufts Medical Center, Boston,
Massachusetts, and approved by the Tufts Medical Center and
Massachusetts Institute of Technology Institutional Review
Boards. The research adhered to the tenets of the Declaration
of Helsinki and complied with the Health Insurance Portability
and Accountability Act of 1996. Written informed consent was
obtained before OCTA imaging.
Patient Selection
Patients with drusen secondary to nonexudative AMD were
seen at the retina service of NEEC between August 2014 and
November 2015 and were recruited to be imaged on SD-OCT
and SS-OCT. The diagnosis of AMD was confirmed by a retinal
specialist on the basis of a complete ophthalmic evaluation
including dilated fundus examination, standard structural SD-
OCT imaging, and FA and/or ICGA as clinically indicated.
Patients with drusen that could be clearly visualized and
delineated on en face OCT and corresponding B-scan images
were included. Large, soft drusen, ‡165 lm, were selected for
analysis by a staff member from the Boston Image Reading
Center who did not participate in image grading. Two trained
readers from the Boston Image Reading Center reviewed and
graded all OCT images. One eye was excluded from the
analysis, as both readers agreed that the image quality was too
poor to allow accurate grading.
Image Acquisition and Analysis
All patients were imaged on SD-OCT and SS-OCT on the same
day. The SD-OCT instrument was the RTVue XR Avanti
(Optovue, Inc., Fremont, CA, USA) with prototype AngioVue
software (software version 2015.0.0.69) for OCTA. This
instrument operates at ~840-nm wavelength and performs
70,000 A-scans per second to acquire OCTA volumes
consisting of two repeated B-scans from 304 uniformly spaced
locations. Each B-scan consists of 304 A-scans for a total of 23
3043 304 A-scans per acquisition, with a total acquisition time
of approximately 3 seconds, and an axial optical resolution of
~5 lm. The interscan time is ~5 ms. Split-spectrum amplitude-
decorrelation angiography (SSADA) is used to improve the
signal-to-noise ratio.34 Motion correction is performed by using
coregistration of two orthogonally acquired volumes.35,36
The SS-OCT device was an ultrahigh speed, 400-kHz A-scan
rate, prototype developed at Massachusetts Institute of
Technology (Cambridge, MA, USA) and deployed to NEEC. It
uses a high-speed vertical cavity surface emitting laser as the
light source and operates at ~1050 nm. A total of five repeated
B-scans from 500 sequential, uniformly spaced locations are
acquired. Each B-scan consists of 500 A-scans, and the
interscan time is ~1.5 ms. A total of 5 3 500 3 500 A-scans
are acquired per OCTA volume with an acquisition time of
~3.8 seconds, and an axial optical resolution of ~8 to 9 lm.37
Motion correction, using the same algorithm as on the SD-OCT
system, was performed. OCTA images were generated by using
an intensity-based pixelwise decorrelation scheme of the form
presented in the study by Jia et al.34; however, the spectrum
was not split. To reduce noise in the SS-OCTA images,
thresholding was performed. The threshold levels were
computed, using the SS-OCT images, by estimating the mean
and standard deviation of the noise, and then setting the
threshold as 2 standard deviations above the noise mean.
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For both systems, the 333 mm acquired OCT volumes were
centered on the fovea. Furthermore, for both systems, images
were obtained by using the vitreoretinal imaging protocol, which
is the default setting in our clinic. The patients were asked to
fixate on an internal target during OCTA acquisition. Drusen were
identified by using OCT B-scans and the patients’ fundus images.
These were then correlated with the 3 3 3 mm OCTA images
from both devices by two independent and masked readers of the
Boston Image Reading Center.
The SD-OCT data were flattened by using the built-in
automatic CC segmentation. The segmentation slab was
manually adjusted by using corresponding structural OCT B-
scans to align the segmentation with Bruch’s membrane. For
the SS-OCT data, a custom Cþþ application was used for
processing, and ImageJ (http://imagej.nih.gov/ij/; provided in
the public domain by the National Institutes of Health,
Bethesda, MD, USA) was used for visualization. The SS-OCT
data were flattened by using an automatic CC segmentation. As
with the SD-OCT data, the segmentation slab was manually
adjusted by using corresponding structural OCT B-scans to
align the segmentation with Bruch’s membrane. For both
systems, en face OCT and OCTA CC slabs were formed by
mean projecting the OCT and OCTA data, respectively, from 30
to 60 lm below the segmented line. Note that for the version
of the Avanti software (2015.0.0.69) available at the time of this
study, mean projection was the default setting.
Ambiguous OCTA signal loss was defined as an area of low
OCTA signal on the en face OCTA CC slab that also had low
OCT signal in the corresponding area on the en face OCT CC
slab and associated OCT B-scans (Figs. 1E, 1F); ambiguous
OCTA signal loss may be due to flow alteration, low OCT signal
(e.g., caused by RPE attenuation), or both. We refer to these
areas as ambiguous because it is not possible, in the absence of
additional information, to determine whether the OCTA signal
loss is caused by true CC alteration or is an artifact of the
thresholding process. Unambiguous OCTA signal loss was
defined as an area of low OCTA signal on the en face OCTA CC
slab that did not have low OCT signal in the corresponding
area on the en face OCT CC slab and associated OCT B-scans
(Figs. 1B, 1C). We refer to these areas as unambiguous OCTA
signal loss because the OCTA signal corresponding to such
areas is unaffected by the thresholding function, that is, it is
reflective of blood flow. This technique for assessing the cause
of low OCTA signal in the CC has previously been described.37
False-positive flow impairment on SS-OCTA was defined as
ambiguous OCTA signal loss on SS-OCTA but no OCTA signal
loss on SD-OCTA; this suggests an SS-OCTA masking artifact,
not true CC alteration. False-positive flow impairment on SD-
OCTA was defined as ambiguous OCTA signal loss on SD-OCTA
but no OCTA signal loss on SS-OCTA; this suggests an SD-OCTA
masking artifact, not true CC alteration.
Grader Analysis
Two observers independently analyzed the en face OCTA CC
slabs from the SS-OCT and SD-OCT instruments. The presence
or absence of low OCTA signal underlying the drusen was
recorded. In patients where there was low OCTA signal
underneath drusen, the images were correlated with the en
face OCT CC slabs and OCT B-scans to classify the region as
either corresponding to ambiguous OCTA signal loss or
unambiguous OCTA signal loss.
Images were graded by two masked independent readers of
the Boston Image Reading Center (ML and EAN). Interreader
reliability was 97.8% (j¼ 0.957, 95% CI: 0.872–1.00). The one
image in which there was disagreement about low OCTA signal
was arbitrated by another retinal specialist (RNL) to provide
the final decision.
RESULTS
Patient Demographics
Nine eyes from seven Caucasian patients with drusen secondary
to AMD were enrolled in this retrospective study. Patients were
classified as having dry AMD after an ophthalmologic examina-
tion and OCT. Patients with advanced AMD that had undergone
FA examination with choroidal neovascularization were exclud-
ed from this study. Five patients (71.4%) were female and two
(28.6%) were male. The mean age of the studied population was
73.1 6 8.0 years (range, 57.5–87.3 years).
Qualitative Analysis
En face OCTA CC slabs underneath 23 drusen were analyzed
using both devices.
Spectral-Domain OCTA Analysis. On the SD-OCTA
device, 17 of the drusen (73.9%) exhibited underlying OCTA
signal loss on the en face SD-OCTA CC slabs. Fourteen of these
areas of OCTA signal loss (82.4%) were classified as ambiguous
based of the low OCT signal levels in the corresponding en
face SD-OCT CC slabs and SD-OCT B-scans (Figs. 2E, 2F). Three
of these areas of OCTA signal loss (17.6%) were classified as
unambiguous. Ten of the 17 areas of OCTA signal loss (58.8%)
were classified as having false-positive flow impairment.
Swept-Source OCTA Analysis. On the SS-OCTA device, 7
of the 23 drusen (30.4%) exhibited underlying loss of the OCTA
signal. All seven of these areas of OCTA signal loss were classified
as unambiguous; correspondingly, no areas were classified as
having false-positive flow impairment (Figs. 2B, 2C).
DISCUSSION
Optical coherence tomography angiography is a noninvasive
technique for rapidly acquiring depth-resolved images of the
retinal and choroidal vasculature. Early and intermediate AMD
is often characterized by the presence of drusen, and
histopathologic studies have indicated that drusen may form
in areas of CC insufficiency.14–17
Our current understanding of AMD has been hindered by
the absence of a modality capable of adequately visualizing the
CC. Notably, both of the gold-standard imaging modalities, FA
and ICGA, have inherent flaws in their ability to image the CC.
The image quality of FA is reduced by the absorption of the
blue–green excitation wavelength of fluorescein by macular
xanthophyll and the RPE. The fine microvascular network of
the choroid is further obscured by leakage of ~20% of the
fluorescein dye that fails to bind to albumin, causing an early
hyperfluorescence.38 Conversely, ICGA, which is considered
the superior modality for imaging the choroid, has not gained
widespread acceptance, as it is not depth resolved, so
separating the CC blood flow from the deeper choroidal
vasculature is a complex task.39,40
Because it does not suffer from the same limitations of dye-
based techniques, OCTA is poised to establish itself as the
standard modality for CC imaging. However, despite its
advantages, OCTA images must be interpreted with care
owing to a variety of image artifacts. As previously mentioned,
OCTA images are typically thresholded on the basis of the OCT
signal level: OCTA pixels whose corresponding OCT signal
level is below a predefined threshold are set to zero. This
thresholding step means that an area having both low OCTA
signal and low OCT signal is ambiguous: the low OCTA signal
may be the result of low flow, low OCT signal, or both. As
OCT signal attenuation is likely to occur at depths below the
RPE and underneath drusen, especially for shorter-wavelength
systems, OCTA of the CC underneath drusen is particularly
susceptible to such attenuation artifacts.41 To the authors’
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FIGURE 1. Example of OCTA signal loss on both the SD-OCT and SS-OCT systems. Note that this figure is intended to illustrate the differences in the
SD-OCTA and SS-OCTA images and is not intended to describe the grading process itself. (A) Fundus photograph. (B) En face SS-OCTA CC slab. (C)
En face SS-OCT CC slab. (D) Swept-source OCT B-scan extracted from the dashed line in (C). (E) En face SD-OCTA CC slab. (F) En face SD-OCT CC
slab. The dashed box in (A) indicates the 33 3 mm field of view over which the SS-OCT and SD-OCT scans were acquired. In (D), a representative
druse is denoted with an asterisk. The dashed contour in (E) highlights an area of OCTA signal loss underlying this drusen. The same contour has
been superposed on images B, C, and F. Note that there is an area of SS-OCTA signal loss, indicated by the arrowhead in (B). Since the
corresponding region in (C) does not exhibit low OCT signal, we classified the SS-OCTA signal loss in (B) as unambiguous. Since the dashed contour
in (F) encircles a region of low SD-OCT signal, we classified the SD-OCTA signal loss in (E) as being ambiguous. Finally, neither the SD-OCTA nor the
SS-OCTA is classified as having false-positive flow impairment.
FIGURE 2. Example of OCTA signal loss on the SD-OCT system, and no OCTA signal loss on the SS-OCT system. Note that this figure is intended
to illustrate the differences in the SD-OCTA and SS-OCTA images, and is not intended to describe the grading process itself. (A) Fundus
photograph. (B) En face SS-OCTA CC slab. (C) En face SS-OCT CC slab. (D) Swept-source OCT B-scan extracted from the dashed line in (C). (E)
En face SD-OCTA CC slab. (F) En face SD-OCT CC slab. The dashed box in (A) indicates the 333 mm field of view over which the SS-OCT and SD-
OCT scans were acquired. In (D), a representative druse is denoted with an asterisk. The dashed contour in (E) highlights an area of OCTA signal
loss underlying this drusen. The same contour has been superposed on images B, C, and F. Note that there is no SS-OCTA signal loss within the
dashed contour of (B). Since the dashed contour in (F) encircles a region of low SD-OCT signal, we classified the SD-OCTA signal loss in (E) as
being ambiguous. Finally, since there is no SS-OCTA loss in (B), we classified the SD-OCTA image as having false-positive flow impairment under
this druse.
Visualizing the Choriocapillaris Under Drusen IOVS j Special Issue j Vol. 57 j No. 9 j OCT588
Downloaded from iovs.arvojournals.org on 06/03/2019
knowledge, a direct comparison of SS-OCTA and SD-OCTA for
visualizing the CC underneath drusen has not been conducted
to date.
Our study indicated that there were fewer drusen with
areas of OCTA signal loss on the longer-wavelength, 1050-nm
SS-OCTA system (n ¼ 7) than on the shorter-wavelength, 840-
nm SD-OCTA system (n¼ 17). Furthermore, 10 of the 17 areas
of OCTA signal loss on SD-OCTA were classified as having false-
positive flow impairment. In comparison, no areas on SS-OCTA
were classified as having false-positive flow impairment. These
results suggest that, when imaging the CC underlying drusen,
longer-wavelength SS-OCTA is less prone to producing thresh-
olding artifacts than shorter wavelength SD-OCTA. Regardless
of the system used, in areas of low OCT signal, loss of OCTA
signal should not be interpreted as CC flow alteration.
When interpreting the results of our study it is important to
note that there are several differences between the two
systems beyond the fact that one is a spectral-domain system
and the other is a swept-source system. First, the wavelengths
used are different: the SD-OCT system uses a shorter, 840-nm,
light source, while the SS-OCT system uses a longer, 1050-nm,
light source. Second, the underlying algorithms used to
generate the OCTA images are different: the SD-OCT system
uses the SSADA algorithm, while the SS-OCT system uses a
different, custom, decorrelation-based approach. In addition, in
any OCTA system, there are numerous processing and display
options, ranging from thresholding levels, to contrast and
brightness settings. Since the SD-OCT was a commercial
system with proprietary software, it was not possible to
equalize all of these settings between the two systems. Thus,
there is the potential that some portion of our observations
was due to such differences. However, we suspect that the
primary factors underlying the observed results are a
combination of signal attenuation, due to the wavelength
difference, and sensitivity roll-off, due to the spectral-domain
detection. With reference to the latter, it is also important to
consider that imaging in our study was performed by using the
vitreoretinal protocol, which is the default setting in our clinic.
If the imaging had been performed in a configuration
optimized for CC imaging, where the CC is near the top of
the B-scan, closer to the zero-delay, the signal loss due to
sensitivity roll-off would have been prevented. However, we
opted to adhere to the vitreoretinal protocol because that is
the standard imaging configuration that is used in our clinics;
that SD-OCT requires different imaging protocols for the CC
and retinal vasculatures in order to mitigate sensitivity roll-off
is, in itself, a limitation of the SD-OCT.
There were several other important limitations to our study.
Our sample size was small and did not cover a range of drusen
types; we only selected large, soft drusen, ‡165 lm. It is
possible that our results do not extend to different drusen
types. Another limitation was that our analysis of OCT and
OCTA signal levels was qualitative, not quantitative. While
quantitative analysis would have been the most definitive
route, because of the many unknown parameters of the
commercial system, it was not feasible. In particular, process-
ing parameters, such as thresholding levels, must be known to
perform a fair quantitative comparison.
CONCLUSIONS
This study suggests that, when imaging the CC beneath drusen,
longer-wavelength, 1050-nm, SS-OCTA is less prone to producing
areas of false-positive flow impairment than shorter-wavelength,
840-nm, SD-OCTA. Perhaps more importantly, this study
underscores the need for careful interpretation of OCTA data,
as there may be multiple factors that cause OCTA signal loss.
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